Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarkers in Chemotherapy-Induced Peripheral Neurotoxicity: Better Tools and Understanding

NCT03348956 is registered in ClinicalTrials.gov with Dartmouth-Hitchcock Medical Center as lead sponsor.

NCT NCT03348956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03348956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarkers in Chemotherapy-Induced Peripheral Neurotoxicity: Better Tools and Understanding
Lead sponsor
Dartmouth-Hitchcock Medical Center
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2018
Completion date
February 14, 2022
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cipn - chemotherapy-induced peripheral neuropathy